Arena Pharmaceuticals Soared On Rumor - NASDAQ:ARNA, GPRC, CLNT, SATC, AEZS

Las Vegas, NV -- (SBWIRE) -- 08/15/2012 -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares climbed 14.09% and closed at $8.26 in the previous trading session on renewed speculation that the company could be an acquisition target after getting FDA’s approval for its new diet drug lorcaserin, also known as Belviq in June. Read the full press release at http://www.sbwire.com/press-releases/arena-pharmaceuticals-soared-on-rumor-nasdaqarna-gprc-clnt-satc-aezs-158953.htm